Icotinib Combined With SBRT for Patients With Metastatic Non-squamous NSCLC With EGFR Mutation
Clinical trial NCT03153358 · UNKNOWN
Trial details
- NCT number
- NCT03153358
- Sponsor
- Sichuan Cancer Hospital and Research Institute
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-02
- Primary completion
- 2017-11-02
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.